The glucocorticoid properties of the synthetic steroid pregna-1,4- diene-11β-ol-3,20-dione (ΔHOP) are not entirely correlated with the steroid binding to the glucocorticoid receptor

Molecular and Cellular Endocrinology

Volumn 149, Issue 1-2, 1999, Pages 207-219

  Vicent, G P ^a   Pecci, A ^b   Ghini, A A ^a   Piwien Pilipuk, G ^a   Veleiro, A S ^a   Burton, G ^a   Lantos, C P ^a   Galigniana, M D ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Apoptosis; Glucocorticoid action; Glucocorticoid receptor; Heat shock protein

Indexed keywords

11BETA HYDROXYPROGESTERONE; 11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; CHLORAMPHENICOL ACETYLTRANSFERASE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLYCOGEN; HEAT SHOCK PROTEIN; LEUCINE; MINERALOCORTICOID RECEPTOR; PREGNA 1,4 DIENE 11BETA OL 3,20 DIONE; PROGESTERONE DERIVATIVE; THYMIDINE; TRANSCORTIN; TYROSINE AMINOTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DEGRADATION; HORMONE RECEPTOR INTERACTION; INFLAMMATION; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; THYMOCYTE; THYMUS;

ANIMALS; APOPTOSIS; CHLORAMPHENICOL O-ACETYLTRANSFERASE; GENES, REPORTER; GLUCOCORTICOIDS; HSP90 HEAT-SHOCK PROTEINS; HYDROXYPROGESTERONES; KIDNEY; KINETICS; LIVER; MALE; MODELS, MOLECULAR; MOLECULAR STRUCTURE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; THYMUS GLAND; TRANSFECTION;

EID: 0033602480     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00205-6     Document Type: Article

References (48)

1. Beato M., Candau R., Chávez S., Möws C., Truss M. Interaction of steroid hormone receptors with transcription factors involves chromatin remodelling. J. Steroid Biochem. Mol. Biol. 56:1996;47-59.
2. Bunone G., Briand P.A., Miksicek R.J., Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15:1996;2174-2183.
3. Burton G., Galigniana M.D., de Lavallaz S., Brachet-Cota A.L., Sproviero E.M., Ghini A.A., Lantos C.P., Damasco M.C. Sodium-retaining activity of some natural and synthetic 21-deoxysteroids. Mol. Pharmacol. 47:1995;535-543.
4. Chalepakis G., Arnemann J., Slater E., Brüller H.J., Gross B., Beato M. Differential gene activation by glucocorticoids and progestins through the hormone regulatory elementof mouse mammary tumor virus. Cell. 53:1988;371-382.
5. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:1987;2745-2752.
6. Duax W.L., Cody V., Griffin J.F., Roher D.C., Weeks C.M. Molecular conformation and protein-binding affinity of progestins. J. Toxicol. Environ. Health. 4:1978;205-227.
7. Edwards C.R., Steward P.M., Burt D., McIntyre M.A., de Kloet M.A., Brett L., Stuntato W.S., Monder C. Localization of 11β-hydroxysteroid dehidrogenase. Lancet. ii:1986;986.
8. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
9. Funder J.W., Pearce P.T., Smith R., Smith A.I. Mineralocorticoid action: target-tissue specificity is enzyme (not receptor) mediated. Science. 242:1988;583-585.
10. Funder J.W. Glucocorticoid receptors. J. Steroid Biochem. Mol. Biol. 43:1994;389-394.
11. Galigniana M.D., Vicent G.P., Lantos C.P., Burton G. Ligand properties of 11,19-oxidoprogesterone: a preliminary report. Ann. Asoc. Quím. Argent. 81:1993;333-340.
12. Galigniana M.D. Stabilty study on renal type I mineralocorticoid receptor. Life Sci. 59:1996;511-521.
13. Galigniana M.D., Vicent G.P., Burton G., Lantos C.P. Features of the shuttle pair 11β-hydroxyprogesterone/11-ketoprogesterone. Steroids. 62:1997;358-364.
14. García I., Martinou I., Tsujimoto Y., Martinou J.C. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science. 258:1992;302-304.
15. Gonzalez M.D., Burton G. A carbon-13 nuclear magnetic resonance study of the 1,4-diene analogues of steroid hormones and related steroids. Org. Magn. Res. 22:1984;586-591.
16. Gould S.J., Subramani S. Firefly luciferase as a tool in molecular and cell biology. Anal. Biochem. 7:1988;5-13.
17. Helftenbein G., Alvarez C.V., Tuohima P., Beato M. Expression of epithelial phenotype is enhanced by v-Ha-ras in rat endometrial cells immortalized by SV40-T antigen. Oncogene. 8:1993;2075-2085.
18. Herrman M., Lorenz H.M., Voll R., Grünke M., Woith W., Kalden J. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 22:1994;5506-5507.
19. Hutchinson K.A., Dittmar K.D., Czar M.J., Pratt W.B. Proof that hsp70 is required for assembly of the glucocorticoid receptor into a heterocomplex with hsp90. J. Biol. Chem. 269:1994;5043-5049.
20. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., Chambon P. Activation of estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 270:1995;1491-1494.
21. Krisman C. A method for the colorimetric estimation of glycogen. Anal. Biochem. 4:1962;17-23.
22. Krozowski Z.S., Funder J.W. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc. Natl. Acad. Sci. USA. 80:1983;6056-6060.
23. L, and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Cell Growth Differ. 6:1995;647-653.
24. Migliaccio A., Di Domenico M., Castoria G., de Falco A., Bontempo P., Nola E., Auricchio F. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15:1996;1292-1300.
25. Oldenburg B.E., Evans-Storms B., Cidlowski J.A. In vivo resistance to glucocorticoid-induced apoptosis in rat thymocytes with normal steroid receptor function in vitro. Endocrinology. 138:1997;810-818.
26. Oltvai Z.N., Korsmeyer S.J. Checkpoints of dueling dimers foil death wishes. Cell. 79:1994;189-192.
27. S. J. Biol. Chem. 272:1997;11791-11798.
28. Pratt W.B., Welsh M.J. Chaperone functions of the heat shock proteins associated with steroid receptors. Sem. Cell Biol. 5:1992;201-211.
29. Pratt W.B., Toft D.O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 18:1997;306-360.
30. 13C-NMR spectroscopy. J. Steroid Biochem. 15:1981;467-472.
31. Rondinone C.M., Schillaci R., Lantos C.P., Roldán A. Appearance and persistence of 11β-hydroxypregna-1,4-diene-3,20-dione effect in vivo. Acta Physiol. Pharmacol. Latinoam. 39:1989;181-188.
32. Rondinone C.M., Schillaci R., Castillo M.B., Roldán A. Inhibitory effect of 11β-hydroxypregna-1,4-diene-3,20-dione (ΔHOP) on lymphocyte proliferation. Clin. Exp. Immunol. 86:1991;311-314.
33. Rondinone C.M., Schillaci R., Roldán A. Anti-inflammatory activity of 11β-hydroxypregna-1,4-diene-3,20-dione. Drug Develop. Res. 26:1992;61-65.
34. Silverstein A.M., Galigniana M.D., Chen M., Owens-Grillo J.K., Chinkers M, Pratt W.B. Protein phosphatase 5 is a major component of glucocorticoid receptor-hsp90 complexes with properties of an FK506 binding immunophilin. J. Biol. Chem. 272:1997;16224-16230.
35. Souness G., Latif S., Laurenzo J., Morris D.J. 11α- and 11β-hydroxy-progesterone are potent inhibitors of 11β-hydroxysteroid dehydrogenase (isoform 1 and 2), confer marked mineralocorticoid activity on corticosterone in the ADX rats. Endocrinology. 136:1995;1809-1812.
36. Strasser A., Harrys A.W., Cory S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:1991;889-899.
37. Svec F., Teubner V., Tate D. Location of the second steroid-binding site on the glucocorticoid receptor. Endocrinology. 125:1989;3103-3108.
38. Thompson E.B. Glucocorticoid insensitivity of P1798 lymphoma cells is associated with production of a factor that attenuates the lytic response. Cancer Res. 51:1991;5551-5556.
39. Thompson E.B. Apoptosis and steroid hormones. Mol. Endocrinol. 8:1994;665-673.
40. Truss M., Chalepakis G., Slater E.P., Mades S., Beato M. Functional interaction of hybrid response elements with wild-type and mutant steroid-hormone receptors. Mol. Cell. Biol. 11:1991;3247-3258.
41. Vanderbilt J., Miesfeld R., Maler B., Yamamoto K. Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol. Endocrinol. 1:1987;68-74.
42. Veis D., Sorensen C., Shutter J., Korsmeyer S. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 75:1993;229-240.
43. Veleiro A.S., Nevado M.V., Monteserín M.C., Burton G. Syntheses of 21-hydroxy-11,19-oxidopregn-4-ene-3,20-dione and 21-hydroxy-6,19-oxidopregn-4-ene-3,20 dione. Steroids. 60:1995;268-271.
44. Vicent, G.P., Burton, G., Lantos, C.P., Galigniana, M.D., 1994. The glucocorticoid effects of 11-ketoprogesterone are 11β-hydroxysteroid dehydrogenase medited. In: XXX Annual Meeting of the Sociedad Argentina de Invastigaciones Bioquímicas, Puerto Iguazú, Misiones, Argentina, abstract 159.
45. 21-Steroids to type II receptors and transcortin. IX International Congress on Hormonal Steroids, Dallas, USA. 1995.
46. Vicent G.P., Monteserín M.C., Veleiro A.S., Burton G., Lantos C.P., Galigniana M. D. 21-Hydroxy-6,19-oxidoprogesterone: a novel synthetic steroid with specific anti-glucocorticoid properties in the rat. Mol. Pharmacol. 52:1997;749-753.
47. Vicent G.P., Burton G., Ghini A.A., Lantos C.P., Galigniana M.D. Influence of calf serum on glucocorticoid-responses of certain progesterone derivatives. J. Steroid Biochem. Mol. Biol. 66:1998;211-216.
48. Zhu X., Liu P. Steroid-dependent activation of androgen receptor in androgen-independent prostate cancer: a possible role for the MAP kinase signal transduction pathway? Mol. Cell. Endocrinol. 134:1997;9-14.